A phase I study of oral panobinostat (LBH589) alone and in combination with docetaxel (Doc) and prednisone in castration-resistant prostate cancer (CRPC)

被引：3
|
作者：
Rathkopf, D. E.
Wong, B. Y.
Ross, R. W.
George, D. J.
Picus, J.
Tanaka, E.
Chen, Y.
Atadja, P.
Yang, W.
Culver, K. W.
Scher, H. I.
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] Nevada Canc Inst, Las Vegas, NV USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
[4] Duke Univ, Med Ctr, Durham, NC USA
[5] Washington Univ, St Louis, MO USA
[6] Novartis Inst Biomed Res, Cambridge, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.5152
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5152
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A phase I/II study of docetaxel in combination with pegylated liposomal doxorubicin in metastatic castration-resistant prostate cancer
    Laber, Damian A.
    Eatrides, Jennifer
    Jaglal, Michael V.
    Haider, Mintallah
    Visweshwar, Nathan
    Patel, Ankita
    MEDICAL ONCOLOGY, 2020, 37 (10)
  • [32] A phase I/II study of docetaxel in combination with pegylated liposomal doxorubicin in metastatic castration-resistant prostate cancer
    Damian A. Laber
    Jennifer Eatrides
    Michael V. Jaglal
    Mintallah Haider
    Nathan Visweshwar
    Ankita Patel
    Medical Oncology, 2020, 37
  • [33] Safety and Efficacy of Docetaxel, Bevacizumab, and Everolimus for Castration-resistant Prostate Cancer (CRPC)
    Gross, Mitchell E.
    Dorff, Tanya B.
    Quinn, David I.
    Diaz, Patricia M.
    Castellanos, Olga O.
    Agus, David B.
    CLINICAL GENITOURINARY CANCER, 2018, 16 (01) : E11 - E21
  • [34] Cabozantinib plus docetaxel and prednisone in metastatic castration-resistant prostate cancer
    Madan, Ravi A.
    Karzai, Fatima H.
    Al Harthy, Munjid
    Petrylak, Daniel P.
    Kim, Joseph W.
    Arlen, Philip M.
    Rosner, Inger
    Theoret, Marc R.
    Cordes, Lisa
    Bilusic, Marijo
    Peer, Cody J.
    Dawson, Nancy A.
    Couvillon, Anna
    Hankin, Amy
    Williams, Moniquea
    Chun, Guin
    Owens, Helen
    Marte, Jennifer L.
    Lee, Min-Jung
    Tomita, Yusuke
    Yuno, Akira
    Trepel, Jane B.
    Lee, Sunmin
    Steinberg, Seth M.
    Gulley, James L.
    Figg, William D.
    Dahut, William L.
    BJU INTERNATIONAL, 2021, 127 (04) : 435 - 444
  • [35] A phase 2 study of intravenous panobinostat in patients with castration-resistant prostate cancer
    Rathkopf, Dana E.
    Picus, Joel
    Hussain, Arif
    Ellard, Susan
    Chi, Kim Nguyen
    Nydam, Thomas
    Allen-Freda, Erin
    Mishra, Kaushal Kishor
    Porro, Maria Grazia
    Scher, Howard I.
    Wilding, George
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (03) : 537 - 544
  • [36] Incidence and Outcomes of Brain and Meningeal Metastases (BMm) in Patients With Castration-resistant Prostate Cancer (CRPC) in the Era of Docetaxel (DOC)
    Caffo, O.
    Gernone, A.
    Ortega, C.
    Sava, T.
    Carteni, G.
    Facchini, G.
    Lo Re, G.
    Bortolus, R.
    Veccia, A.
    Galligioni, E.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S503 - S503
  • [37] A phase 2 study of intravenous panobinostat in patients with castration-resistant prostate cancer
    Dana E. Rathkopf
    Joel Picus
    Arif Hussain
    Susan Ellard
    Kim Nguyen Chi
    Thomas Nydam
    Erin Allen-Freda
    Kaushal Kishor Mishra
    Maria Grazia Porro
    Howard I. Scher
    George Wilding
    Cancer Chemotherapy and Pharmacology, 2013, 72 : 537 - 544
  • [38] Mature results of a randomized phase II study of OGX-011 in combination with docetaxel/prednisone versus docetaxel/prednisone in patients with metastatic castration-resistant prostate cancer
    Chi, K. N.
    Hotte, S. J.
    Yu, E.
    Tu, D.
    Eigl, B.
    Tannock, I.
    Saad, F.
    North, S.
    Powers, J.
    Eisenhauer, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [39] DOSE FINDING AND EFFICACY PHASE 2 STUDY OF INECALCITOL, A NEW VDR AGONIST, IN COMBINATION WITH DOCETAXEL-PREDNISONE REGIMEN FOR CASTRATION-RESISTANT PROSTATE CANCER (CRPC) PATIENTS (PTS)
    Medioni, Jacques
    Deplanque, Gael
    Maurina, Tristan
    Ferrero, Jean-Marc
    Rodier, Jean-Michel
    Raymond, Eric
    Ayllon, Jorge
    Renaux, Stephanie
    Dufour-Lamartinie, Jean-Francois
    Oudard, Stephane
    JOURNAL OF UROLOGY, 2011, 185 (04): : E285 - E286
  • [40] Phase Ib Study of Enzalutamide in Combination with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer
    Morris, Michael J.
    Rathkopf, Dana E.
    Novotny, William
    Gibbons, Jacqueline A.
    Peterson, Amy C.
    Khondker, Zakaria
    Ouatas, Taoufik
    Scher, Howard I.
    Fleming, Mark T.
    CLINICAL CANCER RESEARCH, 2016, 22 (15) : 3774 - 3781
12345